Skip to content

PHARMAZINNES

Active
Private limited companyfounded 2019active for 7 yearsRue Patenier 15, 5000 Namur, BelgiumKBO/BCE: BE 0734.679.978
Summary

PHARMAZINNES has been active since 2019 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €121,685 and a net result of €50,293. Equity has been growing by about 23% per year since 2020. Its solvency ranks better than 24% of 12,757 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.6% (low).

Overview

Official details

Source: KBO
Status
Active since 20-09-2019 Normal situation
Activity
Retail sale of pharmaceutical products NACE 47730
Joint committee
313 Paritair Comité voor de apotheken en tarificatiediensten · annual accounts 2023
Establishment unit
2.294.137.201 5000 Namur, since 20-09-2019
Financial year end
31 December
Peppol
Reachable since 12-12-2025

Board and ownership

Board
  • LELIEVRE DE STAUMONT PAULINE MADELEINEDirector · since 20-09-2019

Financial position

71 Healthy Checked score 2025
Bankruptcy probabilitywithin 12 months
0.6%
Annual accounts 2025
Gross margin
€231,990
▲ 11.8%
Turnover
≈ €1.1m
estimated
Profit
€50,293
▲ 85.3%
Equity
€121,685
▲ 68.5%
Total assets
€875,224
▼ 2.3%
Employees on 31-12-2025
3
▲ 50.0%
Filed on 31-07-2026, on time
Score breakdownraises riskEquity €121,685 (13.9% of total assets)Sector: Retail trade (NACE 47)lowers riskSize: 1.5 FTE, total assets €875,224Figures for financial year 2025 (filed on 31-07-2026)Show the evidence

Checked score

Score 2025
71 / 100
Healthy
Probability in this band: 0.55% to 1.5%
Financially stronger than 61% of micro companies in retail trade (NACE 47)
Financial strength · tick: 2024
Average
Solvency 39+6
equity 13.9% of total assets
Liquidity 55+8
short-term debt 40.9% · cash 19.1%
Profitability 76+3
return on assets 5.7%
Bankruptcy probability within 12 months
0.6% Low
0%0.5%1.5%4%10%≥ 25%

About 6 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,272 companies, NACE 47, micro)
Last 24 months 12-2024: 0.7% 01-2025: 0.6%▼ -0.1 percentage points vs 12-2024 02-2025: 0.6%● unchanged vs 01-2025 03-2025: 0.7%▲ +0.1 percentage points vs 02-2025 04-2025: 0.7%● unchanged vs 03-2025 05-2025: 0.8%▲ +0.1 percentage points vs 04-2025 06-2025: 0.9%▲ +0.1 percentage points vs 05-2025 07-2025: 1.0%▲ +0.1 percentage points vs 06-2025 08-2025: 1.4%▲ +0.4 percentage points vs 07-2025highest value 09-2025: 1.0%▼ -0.4 percentage points vs 08-2025 10-2025: 1.0%● unchanged vs 09-2025 11-2025: 1.0%● unchanged vs 10-2025 12-2025: 0.9%▼ -0.1 percentage points vs 11-2025 01-2026: 0.9%● unchanged vs 12-2025 02-2026: 0.9%● unchanged vs 01-2026 03-2026: 0.9%● unchanged vs 02-2026 04-2026: 0.9%● unchanged vs 03-2026 05-2026: 0.9%● unchanged vs 04-2026 06-2026: 1.0%▲ +0.1 percentage points vs 05-2026 07-2026: 1.2%▲ +0.2 percentage points vs 06-2026 08-2026: 0.6%▼ -0.6 percentage points vs 07-2026lowest value 09-2026: 0.6%● unchanged vs 08-2026lowest value 10-2026: 0.6%● unchanged vs 09-2026lowest value 11-2026: 0.6%● unchanged vs 10-2026lowest value
Credit of up to €8,000 on 30-day terms is acceptable
Liquidity is tight, with a current ratio of 1.06 (0.95 in 2024), below the usual 1.5. Short-term debt is 40.9% and cash 19.1% of total assets. 86.1% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 30% of them on solvency, 60% on liquidity, 63% on profitability and 89% on growth.

The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Six signals.
lowers riskraises riskneutral
raises risk · Equity €121,685 (13.9% of total assets)
NBB · annual accounts
lowers risk · Size: 1.5 FTE, total assets €875,224
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed on 31-07-2026)
NBB · annual accounts
raises risk · Sector: Retail trade (NACE 47)
KBO
raises risk · Weak solvency compared with the sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 24% of 12757 sector peers (2025).
NBB · sector comparison
Position among 12757 sector peers
Solvency
better than 24%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-07-2026, 0 days ahead of the deadline.
NBB · 6 filings
Deviation from the deadline
2025
on the day
2024
8 days late
2023
13 days late
2022
18 days early
2021
23 days early
2020
10 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 6 accounts on average 2 days before the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 31 July (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
02-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: 6 profitable years in a rowprofit 2025: €50,293 6 years View

Recent changes

  1. · Gazette deed Incorporation
All 9 events

Comparable companies

These companies have the same main activity as PHARMAZINNES: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €717,000 and €1m, founded between 2018 and 2020.

CompanyTotal assetsGross margin
PHARMAZINNES Namur€0.9m€0.2m
PHARMA GONRIEUX Viroinval€0.7m€0.3m
PHARMACIE KASSAR Schaarbeek€0.8m€0.2m
PHARMACIE DELDICQUE-LENFANT SRL Tournai€0.8m€0.2m
Apotheek Boelens Neerharen Maasmechelen€1.0m€0.2m
PHARMATRUST Anderlecht€0.7m€0.3m
Het Apotheekhuis Beveren-Kruibeke-Zwijndrecht€0.7m€0.2m
Full comparison

Key facts about PHARMAZINNES

What is the company number of PHARMAZINNES?
The company number of PHARMAZINNES is 0734.679.978. The VAT number is the same number with BE in front: BE 0734.679.978.
Where is PHARMAZINNES based?
The registered office is at Rue Patenier 15, 5000 Namur.Company details
What does PHARMAZINNES do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of PHARMAZINNES?
The legal form of PHARMAZINNES is Private limited company (BV).
When was PHARMAZINNES founded?
PHARMAZINNES was founded on 20-09-2019.
Is PHARMAZINNES still active?
Yes, PHARMAZINNES is an active enterprise in the KBO register.
How many employees does PHARMAZINNES have?
PHARMAZINNES had an average of 1.5 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does PHARMAZINNES fall under?
In its 2023 annual accounts, PHARMAZINNES states joint committee 313 (Paritair Comité voor de apotheken en tarificatiediensten).
What is the turnover of PHARMAZINNES?
The turnover in financial year 2025 is ≈ €1.1m. This figure is estimated from the gross margin of €231,990 and 51 comparable companies (NACE 477). It probably lies between €730,000 and €2.1m.
Is PHARMAZINNES profitable?
In financial year 2025, PHARMAZINNES made a profit of €50,293.
Where can I find the annual accounts of PHARMAZINNES?
PHARMAZINNES filed 6 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of PHARMAZINNES due?
PHARMAZINNES must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.